Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development
Medical product innovation, whether drugs, devices, or biologics, is a continual journey that advances the needs of patients today and of future generations. Innovation takes form in many spaces, such as research, product design, data collection, and analysis, and we’re currently bearing witness to a golden age of technology involving artificial intelligence and genomics. This free session will provide a perspective on the state of the FDA, both with current activities and what’s to come.
Plenary Speakers:
- Patrizia Cavazzoni M.D., Director, Center for Drug Evaluation and Research (CDER)
- Jeff Shuren M.D., J.D., Director, Center for Devices and Radiological Health (CDRH)
- Peter Marks M.D., PhD., Director, Center for Biologics Evaluation and Research (CBER)